PRHSX
Price
$91.73
Change
+$0.36 (+0.39%)
Updated
Nov 18 closing price
Net Assets
12.12B
SHPAX
Price
$22.06
Change
+$0.18 (+0.82%)
Updated
Nov 18 closing price
Net Assets
11.09M
Interact to see
Advertisement

PRHSX vs SHPAX

Header iconPRHSX vs SHPAX Comparison
Open Charts PRHSX vs SHPAXBanner chart's image
T. Rowe Price Health Sciences
Price$91.73
Change+$0.36 (+0.39%)
VolumeN/A
Net Assets12.12B
Saratoga Health & Biotechnology A
Price$22.06
Change+$0.18 (+0.82%)
VolumeN/A
Net Assets11.09M
PRHSX vs SHPAX Comparison Chart in %
View a ticker or compare two or three
VS
PRHSX vs. SHPAX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRHSX is a Hold and SHPAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRHSX has more cash in the bank: 12.1B vs. SHPAX (11.1M). PRHSX pays higher dividends than SHPAX: PRHSX (0.01) vs SHPAX (0.00). PRHSX was incepted earlier than SHPAX: PRHSX (30 years) vs SHPAX (26 years). SHPAX (2.72) is less costly to investors than PRHSX (0.80). PRHSX is a more actively managed with annual turnover of: 52.40 vs. SHPAX (17.00). SHPAX has a lower initial minimum investment than PRHSX: SHPAX (250) vs PRHSX (2500). SHPAX annual gain was more profitable for investors over the last year : 8.75 vs. PRHSX (-0.44). SHPAX return over 5 years is better than : 7.36 vs. PRHSX (-7.00).
PRHSXSHPAXPRHSX / SHPAX
Total Expense Ratio0.802.7229%
Annual Report Gross Expense Ratio0.802.7229%
Fund Existence30 years26 years-
Gain YTD15.34016.44593%
Front LoadN/A6%-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B11.1M109,009%
Annual Yield % from dividends0.010.00-
Returns for 1 year-0.448.75-5%
Returns for 3 years0.722.9225%
Returns for 5 years-7.007.36-95%
Returns for 10 years22.88-29.89-77%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLUE13.780.17
+1.25%
Monte Rosa Therapeutics
PMN0.36N/A
-0.17%
ProMIS Neurosciences
SPR35.87-0.23
-0.64%
Spirit Aerosystems Holdings
VEEV273.72-3.29
-1.19%
Veeva Systems
GENC12.95-0.19
-1.45%
Gencor Industries